($millions) 12/19 12/20 12/21 12/22 12/23 Operating Revenue 508.94 542.63 595.94 617.93 625.74 Other Revenue 0.00 0.00 0.00 0.00 19.26 Total Revenue Excluding Interest 508.94 542.63 595.94 617.93 645.00 Operating Expenses -373.19 -412.26 -455.60 -474.07 -569.68 EBITDA 135.75 130.37 140.34 143.86 75.32 Depreciation -22.42 -23.28 -27.53 -24.57 -23.96 Amortisation -14.82 -16.07 -19.44 -16.08 -27.04 Depreciation and Amortisation -37.24 -39.36 -46.98 -40.66 -51.00 EBIT 98.50 91.02 93.36 103.21 24.32 Interest Revenue 0.55 0.44 0.19 1.01 1.93 Interest Expense -8.72 -8.42 -9.24 -13.70 -23.71 Net Interest Expense -8.17 -7.98 -9.04 -12.69 -21.78 PreTax Profit 90.34 83.03 84.32 90.52 2.54 Tax Expense -23.32 -19.08 -19.07 -15.25 -10.42 Net Profit after Tax Before Abnormals 67.01 63.95 65.25 75.27 -7.88 Abnormals -1.88 -4.88 8.54 -22.60 -129.60 Abnormals Tax 0.00 0.00 0.00 0.00 0.00 Net Abnormals -1.88 -4.88 8.54 -22.60 -129.60 Reported NPAT After Abnormals 65.13 59.07 73.80 52.67 -137.48 Outside Equity Interests 0.00 0.00 0.00 Shares Outstanding at Period End 172.48 190.81 187.18 0.00 184.58 0.00 186.79 Weighted Average Number Of Shares 171.98 183.00 190.36 184.16 179.96 EPS Adjusted (cents/share) 38.69 34.65 34.04 40.01 -4.38 EPS After Abnormals (cents/share) 37.60 32.00 38.50 28.00 -76.40